21 May 2009
Quality of life after kidney and pancreas transplantation
D Zielińska, M DurlikAnn Transplant 2009; 14(1): 45-46 :: ID: 880365
Abstract
Perfused organ transplantation such as transplantation of the whole pancreas
has proved so far to be the best possible way of dealing with type 1 diabetes mellitus. That also includes prevention of its complications. Patients undergoing pancreas-and-kidney surgery are likely to develop post-operative complications, and extensive pharmacological treatment. The likelihood of developing post-operative complications, especially when combined with extensive pharmacological treatment may jeopardize patients' recovery and their quality of life. Recently published data shows, that patients after pancreas and-kidney transplants are likely to have their QoL worse than average in general population, in spite of the fact that they function far better than before the surgery. The aim of this study was to evaluate QoL after pancreas-and kidney transplantation of patients transplanted in our centre. A total of 23 patients were included in the study. Surgical procedures took place between the years 2005 and 2008. In 20 cases pancreas-and-kidney transplant was performed and in 2 cases pancreas transplant was done 2 years after successful kidney transplantation. To evaluate QoL questionnaire QLQ-30 was used, as well as questionnaire BDI (depression assessment) and STAI (anxiety). In all cases the appropriate graft functioning was confirmed.
Results: After at least 6 months following the transplant mean QoL score was 88, mean functioning score was 71.2 and symptoms scale score was 9.1. Average BDI questionnaire score was 8. Four patients have reached 12 points and above. Kidney-and pancreas transplantation significantly improves QoL, although higher scores in anxiety and depression questionnaires are noted.
Keywords: Pancreas Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860